CAREMAX INC (CMAX)
US14171W2026 - Common Stock
CMAX gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 114 industry peers in the Health Care Providers & Services industry. CMAX has a bad profitability rating. Also its financial health evaluation is rather negative. CMAX does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
In the past year CMAX has reported negative net income.
CMAX had a negative operating cash flow in the past year.
CMAX had negative earnings in each of the past 5 years.
In the past 5 years CMAX always reported negative operating cash flow.
1.2 Ratios
CMAX's Return On Assets of -172.42% is on the low side compared to the rest of the industry. CMAX is outperformed by 96.46% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -172.42% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-37.96%
ROA(5y)N/A
ROE(3y)-373.19%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
CMAX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
CMAX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CMAX has been increased compared to 1 year ago.
CMAX has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of -3.21, we must say that CMAX is in the distress zone and has some risk of bankruptcy.
CMAX has a worse Altman-Z score (-3.21) than 84.07% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -3.21 |
ROIC/WACCN/A
WACC8.44%
2.3 Liquidity
CMAX has a Current Ratio of 0.23. This is a bad value and indicates that CMAX is not financially healthy enough and could expect problems in meeting its short term obligations.
CMAX's Current ratio of 0.23 is on the low side compared to the rest of the industry. CMAX is outperformed by 93.81% of its industry peers.
A Quick Ratio of 0.23 indicates that CMAX may have some problems paying its short term obligations.
CMAX's Quick ratio of 0.23 is on the low side compared to the rest of the industry. CMAX is outperformed by 93.81% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.23 | ||
| Quick Ratio | 0.23 |
3. Growth
3.1 Past
CMAX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1080.14%.
The Revenue has grown by 9.06% in the past year. This is quite good.
EPS 1Y (TTM)-1080.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-13.33%
Revenue 1Y (TTM)9.06%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-11.5%
3.2 Future
CMAX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.98% yearly.
CMAX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.33% yearly.
EPS Next Y83.76%
EPS Next 2Y37.58%
EPS Next 3Y24.98%
EPS Next 5YN/A
Revenue Next Year5.97%
Revenue Next 2Y18.46%
Revenue Next 3Y16.94%
Revenue Next 5Y16.33%
3.3 Evolution
4. Valuation
4.1 Price/Earnings Ratio
CMAX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year CMAX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as CMAX's earnings are expected to grow with 24.98% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.58%
EPS Next 3Y24.98%
5. Dividend
5.1 Amount
CMAX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
CAREMAX INC
NASDAQ:CMAX (11/22/2024, 8:00:00 PM)
After market: 0.737 +0.02 (+2.36%)0.72
+0.05 (+7.96%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.74M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -172.42% | ||
| ROE | N/A | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.73
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 0.23 | ||
| Quick Ratio | 0.23 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-1080.14%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y83.76%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)9.06%
Revenue growth 3YN/A
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y